NARA Discovery
Article Details
← Back to Search Results
Journal Article

A new approach to the classification of carcinogenicity

John E. Doe; Alan R. Boobis; Samuel M. Cohen; Vicki L. Dellarco; Penelope A. Fenner-Crisp; Angelo Moretto; Timothy P. Pastoor; Rita S. Schoeny; Jennifer G. Seed; Douglas C. Wolf
Archives of Toxicology · Vol. 96, Issue 9 · pp. 2419-2428 · 2022

Abstract

Concern over substances that may cause cancer has led to various classification schemes to recognize carcinogenic threats and provide a basis to manage those threats. The least useful schemes have a binary choice that declares a substance carcinogenic or not. This overly simplistic approach ignores the complexity of cancer causation by considering neither how the substance causes cancer, nor the potency of that mode of action. Consequently, substances are classified simply as “carcinogenic”, compromising the opportunity to properly manage these kinds of substances. It will likely be very difficult, if not impossible, to incorporate New Approach Methodologies (NAMs) into binary schemes. In this paper we propose a new approach cancer classification scheme that segregates substances by both mode of action and potency into three categories and, as a consequence, provides useful guidance in the regulation and management of substances with carcinogenic potential. Examples are given, including aflatoxin (category A), trichlorethylene (category B), and titanium dioxide (category C), which demonstrate the clear differentiation among these substances that generate appropriate levels of concern and management options.

Bibliographic Information

JournalArchives of Toxicology
PublisherSpringer
Publication Date2022-09-01
Publication Year2022
Volume96
Issue9
Pages2419-2428
Document TypeJournal Article
Print ISSN0340-5761
eISSN1432-0738
DOI10.1007/s00204-022-03324-z

Access Information

NARA Access Coverage1930-01-01~Current
Journal Homepagehttps://www.springer.com/journal/204
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.